Evidence map›Paper›PMID 40227783›Full record

ArticleCancers2025

Tumor Bud Classification in Colorectal Cancer Using Attention-Based Deep Multiple Instance Learning and Domain-Specific Foundation Models.

Mesut Şeker, M Khalid Khan Niazi, Wei Chen, Wendy L Frankel, Metin N Gurcan

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mesut ŞekerDepartment of Electrical and Electronics Engineering, Dicle University, Diyarbakir 21280, Turkey.ORCID 0000-0001-9245-6790
M Khalid Khan NiaziDepartment of Pathology, The Ohio State University, Columbus, OH 43210, USA.
Wei ChenDepartment of Pathology, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0002-9028-622X
Wendy L FrankelDepartment of Pathology, The Ohio State University, Columbus, OH 43210, USA.
Metin N GurcanCenter for Artificial Intelligence Research, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA.ORCID 0000-0002-2421-8229

Funding

An ensemble deep learning model for tumor bud detection and risk stratification in colorectal carcinoma.R01CA276301 · NCI · OHIO STATE UNIVERSITY · PI Wei Chen, Muhammad Khalid Khan Niazi · 2023 to 2026
$2.0M
Efficient and cost-effective breast cancer risk stratification using whole slide histopathology imagesR21CA273665 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GURCAN, METIN NAFI · 2023 to 2024
$394k
NCI NIH HHS R01 CA276301NCI NIH HHS R21 CA273665
6 · The paper itself

Abstract

BACKGROUND/

objectivesIdentifying tumor budding (TB) in colorectal cancer (CRC) is vital for better prognostic assessment as it may signify the initial stage of metastasis. Despite its importance, TB detection remains challenging due to subjectivity in manual evaluations. Identifying TBs remains difficult, especially at high magnification levels, leading to inconsistencies in prognosis. To address these issues, we propose an automated system for TB classification using deep learning.

methodsWe trained a deep learning model to identify TBs through weakly supervised learning by aggregating positive and negative bags from the tumor invasive front. We assessed various foundation models for feature extraction and compared their performance. Attention heatmaps generated by attention-based multi-instance learning (ABMIL) were analyzed to verify alignment with TBs, providing insights into the interpretability of the features. The dataset includes 29 WSIs for training and 70 whole slide images (WSIs) for the hold-out test set.

resultsIn six-fold cross-validation, Phikon-v2 achieved the highest average AUC (0.984 ± 0.003), precision (0.876 ± 0.004), and recall (0.947 ± 0.009). Phikon-v2 again achieved the highest AUC (0.979) and precision (0.980) on the external hold-out test set. Moreover, its recall rate (0.910) was still higher than that of UNI's (0.879). UNI exhibited a balanced performance on the hold-out test set, with an AUC of 0.960 and a precision of 0.968. CtransPath showed strong precision on the external hold-out test set (0.947) but had a slightly lower recall (0.911).

conclusionsThe proposed technique enhances the accuracy of TB assessment, offering potential applications for CRC and other cancer types.

Indexed as

colorectal cancerfoundation modelsmulti-instance learningtumor budding

Identifiers

PMID40227783
PMCPMC11988156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.